Octopi began as a research project in Prakash Lab at Stanford University to create a low-cost automated microscopy solution for malaria diagnosis in low-resource settings, and is now being developed and deployed by a spin-off company, Cephla. Building a global platform for AI-powered disease diagnostics is a collaborative effort - one that no single organization can solve alone. We partner with leading researchers and health experts from around the world to make this vision a reality.
2016 - 2022: First Octopi prototypes
Originally developed at Prakash Lab, Stanford University
2016 - present: Clinical collaborations
Clinical partnerships in over 10 countries in Africa and Asia.
2018 - present: Clinical and field validation studies
2022 - present: Octopi and Squid
Cephla Inc. developing Octopi and Squid, automated microscopes for diagnostics and research.
Next phase
Scaling platform technology globally for detecting malaria and other deadly diseases, and building diagnostic and AI capacity in LMICs.
